The 18 analysts offering 12-month price forecasts for Amgen Inc have a median target of 262.95, with a high estimate of 320.00 and a low estimate of 185.00. The median estimate represents a -0.94% decrease from the last price of 265.44.
The current consensus among 27 polled investment analysts is to Hold stock in Amgen Inc. This rating has held steady since September, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $4.74
Reporting Date Oct 31
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.